Oropharyngeal mucosal epithelial adhesion sites

Oropharyngeal mucosal epithelial adhesion sites refer to the various molecular structures and receptors located on the surface of the epithelial cells lining the oropharynx that facilitate the attachment of microorganisms, inflammatory cells, or neoplastic cells. These sites include a diverse array of molecules such as integrins, cadherins, and specific viral or bacterial receptors (e.g., ACE2 for SARS-CoV-2 or CEACAMs for Neisseria species) that mediate the initial stages of colonization and infection. While these sites are critical for the pathogenesis of various respiratory and systemic diseases, the term itself describes a physiological location and a collection of different proteins rather than a single, discrete therapeutic target. Consequently, drug development typically focuses on the specific individual receptors or ligands involved in these adhesion processes rather than the adhesion sites as a collective entity. Understanding the composition of these sites is essential for developing mucosal vaccines and anti-adhesive therapies aimed at preventing pathogen entry at the portal of infection.

Other names

Oropharyngeal epithelial cell receptorsMucosal attachment sitesPharyngeal epithelial adhesion molecules

Not applicable as this refers to a physiological location/structure rather than a single molecular target.